NTI's Vice President of Biological Programs and Director of the Global Health and Security Initiative underscored the need to tackle the challenge of safeguarding life sciences through a multi-disciplinary and integrated approach that engages both the biomedical science and security communities.
The importance of financial and logistical assistance for former Soviet Union anti-plague facilities in combating biological weapons proliferation. (CNS)
Libya's decision to renounce its WMD programs, a resounding success for the nonproliferation regime. (CNS)
In this testimony, Ms. Holgate discusses U.S. progress toward reducing the threats from nuclear, biological and chemical weapons, where we are heading, and whether we are getting there fast enough.
Dr. Hamburg testifies on important concerns raised by the emergence and ongoing response to the SARS outbreak, as well as broader issues of emerging infections, public health and security.
The evolution of the U.S. Department of Homeland Security and the challenges it will face in implementing its mandate. (CNS)
Evolution of the Biological Weapons Convention, challenges to its legitimacy - the lack of a verification mechanism and advances in biotechnology. (CNS)
Global Partnership Against the Spread of Weapons and Material of Mass Destruction will build upon programs such as Cooperative Threat Reduction. (CNS)
The weapons of mass destruction (WMD) nonproliferation and disarmament activities in Central Asia in the decade following the end of the Cold War. (CNS)
In this testimony, Dr. Hamburg discusses the proposed new Department of Homeland Security and the implications for biosecurity and public health.
Sign up for regular updates on innovative, real-world solutions to existential threats.
